Abstract:Dipeptidyl peptidase 4 (DPP4) inhibitors can effectively inhibit the activity of DPP4, increasing the concentrations of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which allows for them to effectively contribute to the reduction of blood sugar levels. Leu-Pro-Ala-Val-Thr-Ile-Arg (LPAVTIR) and Leu-Pro-Pro-Glu-His-Asp-Trp-Arg (LPPEHDWR) were the two peptides with the strongest inhibitory activity against DPP4 selected from silkworm pupa proteins. In this study, four systems were established: Apo (ligand-free DPP4), IPI (IPI-bound DPP4), LPAVTIR (LPAVTIR-bound DPP4), LPPEHDWR (LPPEHDWR-bound DPP4), and Gaussian accelerated molecular dynamic (GaMD) simulation was conducted to investigate the mechanism of action of two inhibitory peptides binding to DPP4. Our study revealed that the LPAVTIR peptide possessed a more stable structure and exhibited a tighter binding to the Ser630 active site in DPP4, thus exhibiting a favorable competitive inhibition effect. In contrast, the LPPEHDWR peptide caused the horizontal α-helix (residues 201–215) composed of Glu205 and Glu206 residues in DPP4 to disappear. The spatial arrangement of active sites Ser630 relative to Glu205 and Glu206 was disrupted, resulting in enzyme inactivation. Moreover, the size of the substrate channel and cavity volume was significantly reduced after the binding of the inhibitory peptide to the protein, which was an important factor in the inhibition of the enzyme activity. A similar effect was also found from IPI (our positive control). By stabilizing the active site of DPP4, the IPI peptide induced the disappearance of the horizontal α-helix and a notable reduction in the active cavity volume. In conclusion, our study provided a solid theoretical foundation for the inhibitory mechanisms of IPI, LPAVTIR, and LPPEHDWR on DPP4, offering valuable insights for advancing the development of drug targets for type 2 diabetes.

Inhibition of Dipeptidyl Peptidase Ⅳ (DPP-Ⅳ) by Three Casein-Derived Bioactive Peptides in Vitro

Susceptibility of Milk Protein-Derived Peptides to Dipeptidyl Peptidase Iv (Dpp-Iv) Hydrolysis

Identification of Two Novel Dipeptidyl Peptidase-Iv Inhibitory Peptides from Sheep Whey Protein and Inhibition Mechanism Revealed by Molecular Docking

Characterization of DPP-IV Inhibitory Peptides Using an in Vitro Cell Culture Model of the Intestine

Study on the Mechanism of Interaction between Dipeptidyl Peptidase 4 and Inhibitory Peptides Based on Gaussian Accelerated Molecular Dynamic Simulation

Structure activity relationship modelling of milk protein-derived peptides with dipeptidyl peptidase IV (DPP-IV) inhibitory activity

Enzymatic Characterization and Synergistic Effects of Protease Combinations on DPP-IV Inhibitory Peptide Release from Bovine Casein

Molecular Mechanistic Insights into Dipeptidyl Peptidase-IV Inhibitory Peptides to Decipher the Structural Basis of Activity

Construction of Screening Model for Dipeptidyl Peptidase IV in vitro andActive Inhibitory Estimation of Related Compounds

Dipeptidyl Peptidase IV Inhibitory Peptides from Chlorella Vulgaris: in Silico Gastrointestinal Hydrolysis and Molecular Mechanism

Identification of the DPP-IV Inhibitory Peptides from Donkey Blood and Regulatory Effect on the Gut Microbiota of Type 2 Diabetic Mice.

3D-QSAR, in vitro assay and MD simulations studies on the design, bioactivities and different inhibitory modes of the novel DPP-IV inhibitory peptides

Mechanistic Study of Novel Dipeptidyl Peptidase IV Inhibitory Peptides from Goat’s Milk Based on Peptidomics and in Silico Analysis

Preparation and Identification of Dipeptidyl Peptidase IV Inhibitory Peptides from Quinoa Protein.

Discovery of Novel Dipeptidyl Peptidase-Iv Inhibitory Peptides Derived from Walnut Protein and Their Bioactivities in Vivo and in Vitro

Collagen derived Gly-Pro-type DPP-IV inhibitory peptides: Structure-activity relationship, inhibition kinetics and inhibition mechanism

Two Novel Peptides Derived from Oat with Inhibitory Activity Against Dipeptidyl Peptidase-Iv: the Related Mechanism Revealed by Molecular Docking and in Vitro and in Situ Effects

In Vitro Metabolic Stability of a Casein-Derived Dipeptidyl Peptidase-IV (DPP-IV) Inhibitory Peptide VPYPQ and Its Controlled Release from Casein by Enzymatic Hydrolysis

Isolation and Identification of Dipeptidyl Peptidase-Iv Inhibitory Peptides from Sacha Inchi Meal

Preparation and Identification of Novel DPP-IV Inhibitory Peptides from Musculus Senhousei: Peptidomic Analysis, Molecular Simulation, and Validation

Identification of Dipeptidyl Peptidase-Iv Inhibitory Peptides from Mare Whey Protein Hydrolysates